Sections View Full Chapter Figures Tables Videos Annotate Full Chapter Figures Tables Videos Supplementary Content +++ Key Features +++ Essentials of Diagnosis ++ Abdominal pain, polyuria, polydipsia, hypertension, nephrocalcinosis, failure to thrive, renal stones, intractable peptic ulcer, constipation, uremia, and pancreatitis Bone pain or pathologic fractures, subperiosteal bone resorption, renal parenchymal calcification or stones, and osteitis fibrosa cystica Impaired concentration, altered mental status, mood swings, and coma +++ General Considerations ++ Hypercalcemia is defined as a serum calcium level > 11 mg/dL Severe hypercalcemia is a level > 13.5 mg/dL More than 80% of hypercalcemic children or adolescents have either hyperparathyroidism or a malignant tumor Hyperparathyroidism is rare in childhood and may be primary or secondary Most common cause of primary hyperparathyroidism is parathyroid adenoma Most common cause of secondary hyperparathyroidism is chronic kidney disease with impaired phosphate excretion +++ Clinical Findings +++ Symptoms and Signs ++ Due to hypercalcemia Manifestations include hypotonicity and muscle weakness; apathy, mood swings, and bizarre behavior; nausea, vomiting, abdominal pain, constipation, and weight loss; hyperextensibility of joints; and hypertension, cardiac irregularities, bradycardia, and shortening of the QT interval Coma occurs rarely Calcium deposits occur in the cornea or conjunctiva (band keratopathy) and are detected by slit-lamp examination Due to increased calcium and phosphate excretion Loss of renal concentrating ability causes polyuria, polydipsia, and calcium phosphate deposition in renal parenchyma or as urinary calculi with progressive renal damage Due to changes in the skeleton Initial findings include bone pain, osteitis fibrosa cystica, subperiosteal bone absorption in the distal clavicles and phalanges, absence of lamina dura around the teeth, spontaneous fractures, and moth-eaten appearance of the skull on radiographs Later, there is generalized demineralization with high risk of subperiosteal cortical bone +++ Diagnosis ++ Bone changes may be subtle in children Technetium sestamibi scintigraphy is preferred over conventional procedures (ultrasound, computed tomography, and MRI) for localizing parathyroid tumors +++ Treatment ++ Initial management is vigorous hydration with normal saline and forced calcium diuresis with a loop diuretic such as furosemide (1 mg/kg given every 6 hours) If response is inadequate, glucocorticoids or calcitonin may be used Bisphosphonates are being used more often in refractory pediatric hypercalcemia Resection of parathyroid adenoma or subtotal removal of hyperplastic parathyroid glands is the preferred treatment Treatment of secondary hyperparathyroidism from chronic kidney disease is primarily directed at controlling serum phosphorus levels with phosphate binders Pharmacologic doses of calcitriol are used to suppress PTH secretion Long-term therapy for hypercalcemia of malignancy is the treatment of the underlying disorder There is also an increasing role for bisphosphonates in treatment of chronic hypercalcemia +++ Outcome +++ Prognosis ++ Excellent after resection of a single adenoma Usually good following subtotal parathyroidectomy for diffuse hyperplasia or removal of multiple adenomas; depends on correction of the underlying defect In patients with multiple sites of parathyroid ... Your Access profile is currently affiliated with [InstitutionA] and is in the process of switching affiliations to [InstitutionB]. Please select how you would like to proceed. Keep the current affiliation with [InstitutionA] and continue with the Access profile sign in process Switch affiliation to [InstitutionB] and continue with the Access profile sign in process Get Free Access Through Your Institution Learn how to see if your library subscribes to McGraw Hill Medical products. Subscribe: Institutional or Individual Sign In Error: Incorrect UserName or Password Username Error: Please enter User Name Password Error: Please enter Password Sign in Forgot Password? Forgot Username? Sign in via OpenAthens Sign in via Shibboleth You already have access! Please proceed to your institution's subscription. Create a free profile for additional features.